Clinical Trial Update: Myeloablative Allogeneic Stem Cell Transplantation Using a Naive T-Cell Depleted Peripheral Blood Stem Cell Graft [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating myeloablative allogeneic stem cell transplantation with a naive T-cell depleted peripheral blood graft has been terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Non-hodgkin Lymphoma

Snippet

Sponsor: Duke University | Conditions: ALL, ANLL | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2013-11-25